Author guidelines

1. Article Types and Language

The European Chemistry and Biotechnology Journal (EUCHEMBIOJ) publishes original research articles presenting novel experimental or computational findings at the interface of chemistry and biotechnology.

  • Article type: Original Research Article (full-length or short article)
  • Publication language: English

Review articles, case reports, commentaries, perspectives, and opinion articles are not considered for publication in EUCHEMBIOJ. Such submissions may be directed to the journal’s companion publication, EUCHEMBIOJ Reviews.

2. Manuscript Preparation

Manuscripts must be prepared using the official journal template, available on the journal website.

  • File format: MS Word
  • Continuous line numbering must be used
  • Figures and tables should be embedded in the text at appropriate positions

Citation Style

  • APA (7th edition)
  • Authors are strongly encouraged to include DOIs where available.

3. Manuscript Structure

Manuscripts should include the following sections, in order:

  • Title
  • Abstract (maximum 500 words)
  • Keywords (3–6 keywords, listed alphabetically)
  • Introduction
  • Materials and Methods
  • Results and Discussion
  • Conclusion
  • Acknowledgements (if applicable)
  • Funding
  • Conflict of Interest Statement
  • Data Availability Statement
  • Ethics Committee Approval (if applicable)
  • Authors’ Contribution Statement
  • Use of Artificial Intelligence (AI)
  • References

A graphical abstract is optional but strongly recommended to enhance article visibility.

4. Title Page (Submitted Separately)

The title page must be uploaded as a separate file and include:

  • Full title of the manuscript
  • Full names of all authors
  • Institutional affiliations
  • Research Organization Registry (ROR) ID for each affiliated institution (where available)
  • Corresponding author’s email address
  • ORCID iDs of all authors

To ensure double-blind peer review, author names and affiliations must not appear in the main manuscript file.

5. Abstract and Keywords

  • The abstract should briefly describe the background, methods, key results, and conclusions.
  • Keywords must accurately reflect the content of the manuscript.

6. Ethics, Research Integrity, and Reporting Standards

i. Ethics Approval and Informed Consent

Research involving humans or animals must comply with international ethical standards. Authors must state:

  • The name of the approving ethics committee
  • Approval number and institution
  • Confirmation of informed consent, where applicable

If ethics approval is not required, this must be explicitly stated.

Data Availability

A Data Availability Statement is mandatory.
Example:

“The data supporting the findings of this study are available from the corresponding author upon reasonable request.”

Conflict of Interest

All authors must disclose any financial or non-financial conflicts of interest.
If none exist, authors should state:

“The authors declare no conflict of interest.”

ii. Reporting guidelines

The European Chemistry and Biotechnology Journal (EUCHEMBIOJ) is committed to transparency, reproducibility, and high reporting standards in scientific publishing. Authors are required to prepare and report their manuscripts in accordance with internationally recognized reporting guidelines relevant to their study design.

Authors should follow the appropriate reporting guideline, including but not limited to:

  • CONSORT (Consolidated Standards of Reporting Trials) for randomized controlled trials

  • STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) for observational studies

  • PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) for systematic reviews and meta-analyses

  • ARRIVE (Animal Research: Reporting of In Vivo Experiments) for animal studies

  • CARE (CAse REport guidelines) for clinical case reports

  • CHEERS for health economic evaluations, where applicable

Authors are encouraged to consult the EQUATOR Network (https://www.equator-network.org) for a comprehensive and up-to-date list of reporting guidelines.

Reporting Checklist Submission

Where applicable, authors must submit the relevant reporting checklist (e.g., CONSORT, PRISMA, STROBE) as a supplementary file at the time of manuscript submission. The completed checklist should indicate page numbers where each reporting item is addressed in the manuscript.

Compliance and Editorial Assessment

Adherence to appropriate reporting guidelines is assessed during the editorial and peer review process. Manuscripts that fail to comply with applicable reporting standards may be returned to the authors for revision or rejected prior to peer review.

iii. Publication consent (Case Reports, identifiable images, and personal data)

The European Chemistry and Biotechnology Journal (EUCHEMBIOJ) requires explicit consent for the publication of case reports, identifiable images, and any personal or sensitive data relating to individual participants.

Case Reports and Individual-Level Data

For manuscripts reporting case studies, case series, or detailed individual-level clinical information, authors must confirm that written informed consent for publication was obtained from the individual(s) concerned or their legally authorized representative.

The consent must specifically cover:

  • Publication of clinical details;
  • Publication in an open-access journal;
  • Online dissemination without access restrictions.

Identifiable Images and Personal Data

If a manuscript includes photographs, videos, radiological images, or other materials in which an individual may be identifiable—directly or indirectly—authors must:

  • Obtain explicit written consent for publication from the individual(s);
  • Ensure that consent covers publication in both print and electronic formats;
  • Confirm that anonymization alone is insufficient where identification remains possible.

Vulnerable Populations

For minors, deceased individuals, or persons unable to provide informed consent, permission must be obtained from a parent, legal guardian, or legally authorized representative, in accordance with applicable laws and ethical standards.

Consent Statement in the Manuscript

Manuscripts must include a Publication Consent Statement, typically under the Ethics Approval and Informed Consent section, clearly stating one of the following:

  • “Written informed consent for publication of this case report and any accompanying images was obtained from the participant.”
  • “Written informed consent for publication was obtained from the patient’s legal guardian.”
  • “The authors confirm that all personal data have been fully anonymized and that informed consent for publication was obtained.”

If consent could not be obtained, authors must provide a clear justification. Manuscripts lacking appropriate publication consent will not be considered for publication.

Data Protection and Confidentiality

All personal data must be handled in accordance with applicable data protection regulations, including the General Data Protection Regulation (GDPR) where applicable. Authors are responsible for ensuring that participant privacy, dignity, and confidentiality are fully respected.

Editorial Review and Verification

The editorial office may request documentation of publication consent at any stage of the editorial or review process. Failure to provide adequate consent documentation may result in rejection of the manuscript or post-publication corrective action, including retraction.

7. Use of Artificial Intelligence (AI) and Generative AI Tools

Authors may use artificial intelligence (AI) and generative AI tools (e.g., for language editing, grammar checking, or formatting) provided that such use is transparent and does not replace the authors’ intellectual contribution.

The following principles must be observed:

  • AI tools must not be listed as authors or co-authors.
  • Authors remain fully responsible for the accuracy, originality, and integrity of the content.
  • AI tools must not be used to generate, fabricate, falsify, or manipulate research data, images, or results.
  • Any use of AI tools beyond basic language editing must be clearly disclosed in the manuscript (e.g., in the Acknowledgements or a dedicated statement).

Undisclosed or inappropriate use of AI tools may be considered a breach of publication ethics and handled in accordance with COPE guidelines.

8. Authorship and Contributions

Authorship must be limited to individuals who have made substantial contributions to the conception, design, execution, or interpretation of the study, in accordance with ICMJE guidelines.

An Authors’ Contribution Statement is mandatory.
Example:

Study design: X.Y., A.B.; Data collection: X.Y.; Analysis: A.B.; Manuscript drafting: X.Y.; All authors reviewed and approved the final manuscript.

Authorship Changes

Requests for addition, deletion, or rearrangement of authors are only permitted before manuscript acceptance and require written approval from all authors and editorial approval. Changes after acceptance are considered only in exceptional circumstances.

9. Originality and Plagiarism

Submitted manuscripts must be original, unpublished, and not under consideration elsewhere.
All submissions undergo plagiarism screening using similarity detection software. Manuscripts with unacceptable similarity levels will be rejected.

10. Peer Review Process

All manuscripts are subject to double-blind peer review by at least two independent experts.
Editorial decisions are based solely on scientific merit, originality, methodological rigor, and relevance to the journal’s scope.

11. Image Integrity

Image manipulation that alters or misrepresents the original data is not permitted. Authors must retain original image data and may be asked to provide it during review.

12. Submission Files

Authors must upload the following files separately:

  1. Cover letter
  2. Title page
  3. Main manuscript file (anonymous)

13. Author Declaration (During Submission)

By submitting a manuscript, authors confirm that:

  • The work is original and has not been published or submitted elsewhere
  • All authors have approved the submission
  • The manuscript complies with ethical standards
  • The article will be published under the Creative Commons Attribution–NonCommercial 4.0 (CC BY-NC 4.0) license if accepted

14. Correspondence

All correspondence regarding the submission and review process will be conducted through the journal’s online system and addressed to the corresponding author.